{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:07:03Z","timestamp":1781896023686,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R41CA186431"],"award-info":[{"award-number":["R41CA186431"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijrobp.2019.05.062","type":"journal-article","created":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T01:50:37Z","timestamp":1559699437000},"page":"400-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["BIO 300, a Nanosuspension of Genistein, Mitigates Radiation-Induced Erectile Dysfunction and Sensitizes Human Prostate Cancer Xenografts to Radiation Therapy"],"prefix":"10.1016","volume":"105","author":[{"given":"Isabel L.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rada","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen A.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Q.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Eley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Kaytor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeljko","family":"Vujaskovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2019.05.062_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3322\/caac.21349","article-title":"Cancer treatment and survivorship statistics, 2016","volume":"66","author":"Miller","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijrobp.2006.12.015","article-title":"Sexual function after three-dimensional conformal radiotherapy for prostate cancer: Results from a dose-escalation trial","volume":"68","author":"van der Wielen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijrobp.2009.01.070","article-title":"Time of decline in sexual function after external beam radiotherapy for prostate cancer","volume":"76","author":"Siglin","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib5","first-page":"124","article-title":"Radiotherapy for prostate cancer and sexual health","volume":"4","author":"Incrocci","year":"2015","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1464-410X.2008.07668.x","article-title":"Phosphodiesterase type 5 inhibitors in the management of erectile dysfunction secondary to treatments for prostate cancer: Findings from a Cochrane systematic review","volume":"102","author":"Candy","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib7","first-page":"CD005540","article-title":"Interventions for sexual dysfunction following treatments for cancer","author":"Miles","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib8","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMcp067261","article-title":"Erectile dysfunction","volume":"357","author":"McVary","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.juro.2014.02.097","article-title":"Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer","volume":"192","author":"Zelefsky","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib10","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jama.2014.2626","article-title":"Tadalafil for prevention of erectile dysfunction after radiotherapy for prostate cancer: The Radiation Therapy Oncology Group [0831] randomized clinical trial","volume":"311","author":"Pisansky","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib11","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.mehy.2004.11.046","article-title":"Isoflavones made simple - genistein\u2019s agonist activity for the beta-type estrogen receptor mediates their health benefits","volume":"66","author":"McCarty","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib12","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1210\/endo.139.10.6216","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib13","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1073\/pnas.97.11.5936","article-title":"Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus","volume":"97","author":"Weihua","year":"2000","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib14","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0731830100","article-title":"Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis","volume":"100","author":"Shim","year":"2003","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib15","doi-asserted-by":"crossref","first-page":"ra22","DOI":"10.1126\/scisignal.2001551","article-title":"Estrogen regulates tumor growth through a nonclassical pathway that includes the transcription factors ERbeta and KLF5","volume":"4","author":"Nakajima","year":"2011","journal-title":"Sci Signal"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib16","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/bcr3619","article-title":"Estrogen receptor beta as a novel target of androgen receptor action in breast cancer cell lines","volume":"16","author":"Rizza","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/clpt.2010.226","article-title":"Estrogen receptors: Therapies targeted to receptor subtypes","volume":"89","author":"Nilsson","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib18","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1073\/pnas.111150898","article-title":"A role for estrogen receptor beta in the regulation of growth of the ventral prostate","volume":"98","author":"Weihua","year":"2001","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib19","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1111\/bph.14056","article-title":"BIO 300, a nanosuspension of genistein, mitigates pneumonitis\/fibrosis following high-dose radiation exposure in the C57L\/J murine model","volume":"174","author":"Jackson","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib20","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1007\/s11095-017-2200-9","article-title":"Targeted metabolomics identifies pharmacodynamic biomarkers for BIO 300 mitigation of radiation-induced lung injury","volume":"34","author":"Jones","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib21","doi-asserted-by":"crossref","first-page":"1214.e1-e6","DOI":"10.1016\/j.urology.2014.12.020","article-title":"Pilot study evaluating a rat model of radiation-induced erectile dysfunction using an image-guided microirradiator","volume":"85","author":"Kimura","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ijrobp.2017.06.2449","article-title":"Cavernous nerve injury by radiation therapy may potentiate erectile dysfunction in rats","volume":"99","author":"Mahmood","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0022-5347(17)38543-9","article-title":"The characterization of a bioassay for rat erectile function","volume":"145","author":"Heaton","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib24","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/j.1743-6109.2009.01272.x","article-title":"Changes in the penile arteries of the rat after fractionated irradiation of the prostate: A pilot study","volume":"6","author":"van der Wielen","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1148\/radiology.195.1.7534430","article-title":"Radiation-induced decrease in nitric oxide synthase\u2014containing nerves in the rat penis","volume":"195","author":"Carrier","year":"1995","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib26","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2174\/187152012803833107","article-title":"Bioavailability and pharmacokinetics of genistein: mechanistic studies on its ADME","volume":"12","author":"Yang","year":"2012","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.critrevonc.2005.06.006","article-title":"Sexual function after external-beam radiotherapy for prostate cancer: What do we know?","volume":"57","author":"Incrocci","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1743-6109.2008.01170.x","article-title":"Predictors of response to sildenafil citrate following radiation therapy for prostate cancer","volume":"6","author":"Teloken","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13014-014-0275-6","article-title":"Hypofractionated radiotherapy for prostate cancer","volume":"9","author":"Hegemann","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2019.05.062_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3857\/roj.2013.31.4.199","article-title":"Whole pelvic intensity-modulated radiotherapy for high-risk prostate cancer: A preliminary report","volume":"31","author":"Joo","year":"2013","journal-title":"Radiat Oncol J"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619308168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301619308168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T22:38:36Z","timestamp":1569019116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301619308168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0360301619308168"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.05.062","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BIO 300, a Nanosuspension of Genistein, Mitigates Radiation-Induced Erectile Dysfunction and Sensitizes Human Prostate Cancer Xenografts to Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2019.05.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}